4 Results for "

BA 1049

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "BA 1049" in MCE Product Catalog:

Cat. No.: HY-162596
CAS No.: 1973494-16-4
Synonyms: BA-1049 free BAse
Target:  

ROCK

Research Areas:  

Neurological Disease

NRL-1049 (BA-1049 (free base)) is an orally available and selective ROCK2 inhibitor with IC50 values of 0.59 µM for ROCK2 and 26 µM for ROCK1, respectively. NRL-1049 modulates ROCK signaling, preserves blood-brain barrier integrity, reduces edema, seizures and hemorrhage, and alleviates cerebral cavernous malformation lesion burden. NRL-1049 can be used for the study of acute brain injury, ischemic stroke, and cerebral cavernous malformations .
loading...
    loading...
Cat. No.: HY-126432
CAS No.: 1973494-17-5
Synonyms: BA-1049
Target:  

ROCK

Research Areas:  

Neurological Disease

NRL-1049 dihydrochloride (BA-1049) is a selective and orally active rho-associated protein kinase 2 (ROCK2) inhibitor with an IC50 of 0.59 μM. NRL-1049 dihydrochloride shows selectivity for ROCK2 is 44 times that of ROCK1 (IC50 = 26 μM). NRL-1049 dihydrochloride can preserve the blood-brain barrier after acute injury .
loading...
    loading...
Cat. No.: HY-126432S
Synonyms: (Rac)-BA-1049-d5
(Rac)-NRL-1049-d5 dihydrochloride ((Rac)-BA-1049-d5) is deuterated labeled (Rac)-NRL-1049.
loading...
    loading...
Cat. No.: HY-162596A
CAS No.: 863638-93-1
Synonyms: (Rac)-BA-1049
Target:  

ROCK

Research Areas:  

Neurological Disease

(Rac)-NRL-1049 is the racemic mixture of NRL-1049 (BA-1049 (free base)) (HY-162596). NRL-1049 is an orally available and selective ROCK2 inhibitor with IC50 values of 0.59 µM for ROCK2 and 26 µM for ROCK1, respectively. NRL-1049 modulates ROCK signaling, preserves blood-brain barrier integrity, reduces edema, seizures and hemorrhage, and alleviates cerebral cavernous malformation lesion burden. NRL-1049 can be used for the study of acute brain injury, ischemic stroke, and cerebral cavernous malformations .
loading...
    loading...